| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 03/01/2006 | CN1243537C Use of composition containing at least one oxidative sensitive hydrophilic active ingredient through at least one maleic anhydride copolymer stabilization at cosmetic and /or skin |
| 02/28/2006 | US7005527 Process for the production of beraprost and its salts |
| 02/28/2006 | US7005521 Catalytic compositions and methods for asymmetric allylic alkylation |
| 02/28/2006 | US7005448 Aminoalkyl-benzofuran-5-ol compounds for the treatment of glaucoma |
| 02/28/2006 | CA2331877C Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/23/2006 | US20060041169 Preparation of n-substituted 2,7-dialkyl-4-hydroxy-5-amino-8-aryl-octanoyl amides |
| 02/23/2006 | US20060041014 Treatment of male sexual dysfunction |
| 02/23/2006 | US20060040933 Antiinflammatory agents |
| 02/23/2006 | US20060039937 Composition having antioxidant properties |
| 02/23/2006 | DE19911504B4 Verfahren zur industriellen Oxidation von Alkoholen, Aldehyden oder Polyhydroxyverbindungen A process for the industrial oxidation of alcohols, aldehydes or polyhydroxy compounds |
| 02/23/2006 | DE102004039281A1 UV Filter UV filter |
| 02/23/2006 | CA2576645A1 Enantioselective synthesis of 13-oxotricyclo[8.2.1.0 3,8]trideca-3(8),4,6-triene-5-carboxylates |
| 02/23/2006 | CA2576388A1 Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity |
| 02/22/2006 | EP1627880A1 Boronic ester and acid compounds, synthesis and uses |
| 02/22/2006 | EP1627873A1 Benzofuran compound and medicinal composition containing the same |
| 02/22/2006 | EP1627638A1 Fortifier |
| 02/22/2006 | EP1626966A1 Benzofuran inhibitors of factor viia |
| 02/22/2006 | EP1626951A1 Compounds for use as a medicine increasing the contractility of a heart, a heart muscle or cells of a heart muscle |
| 02/22/2006 | EP1626712A2 Saururus cernuus compounds that inhibit cellular responses to hypoxia |
| 02/22/2006 | EP1537095B1 Process for preparing functionalized gamma-butyrolactones from mucohalic acid |
| 02/22/2006 | CN1738797A Substituted aryl thioureas and related compounds; inhibitors of viral replication |
| 02/22/2006 | CN1738605A Process for modifying drug crystal formation |
| 02/22/2006 | CN1736996A Novel method for producing methyl hexahydrobenzene anhydride |
| 02/22/2006 | CN1243003C Aspertoxin P as compound with antineoplastic activity |
| 02/22/2006 | CN1242741C Preparation and diabetic use of gibberellins |
| 02/21/2006 | US7002025 Process for the preparation of citalopram |
| 02/21/2006 | US7001926 Tubulin binding agents and corresponding prodrug constructs |
| 02/21/2006 | US7001923 Taxol enhancer compounds |
| 02/21/2006 | US7001625 Solid phase synthesis of salts of organic acids including butyric acid |
| 02/21/2006 | CA2250347C Piperazine and piperidine compounds with high affinity for dopamine-d2 and serotonin-5ht1a receptors |
| 02/21/2006 | CA2184691C L-n6-(1-iminoethyl)lysine derivatives useful as nitric oxide synthase inhibitors |
| 02/16/2006 | US20060036103 Process for preparing a deuterated or tritiated compound |
| 02/16/2006 | US20060035967 Novel phthalamide derivatives |
| 02/16/2006 | US20060035964 Hypoglycemic agent, liver protecting agent and anticancer agent containing lignans originating in hongdoushan |
| 02/16/2006 | US20060035870 Carboxylic acid derivatives as IP antagonists |
| 02/16/2006 | US20060035865 Lipid-rich plaque regressing agents |
| 02/16/2006 | DE102004024504A1 Neue Cylopenta[b]benzofuran-Derivate und ihre Verwendung New Cylopenta [b] benzofuran derivatives and their use |
| 02/15/2006 | EP1625112A1 Novel compounds for treatment of obesity |
| 02/15/2006 | EP1189871B1 Aromatic esters for marking or tagging organic products |
| 02/15/2006 | CN1735608A Substituted benzoyl derivatives as herbicides |
| 02/15/2006 | CN1735589A Method for preparing 4-hydroxyisoleucine diastereoisomers and enantiomers and derivatives thereof |
| 02/15/2006 | CN1733768A Bilobalide extraction and purification process |
| 02/15/2006 | CN1733750A Method for separating effective ingredient lagehead atractylodes lactone ó¾ from lagehead atractylodes naphtha |
| 02/15/2006 | CN1733749A Industrial production method of mycophenolic acid morpholine ester |
| 02/15/2006 | CN1733748A Cyclohexenone analog bicyclo (condensed ring) compound and its preparation method and uses |
| 02/15/2006 | CN1733747A Method for extracting Vitamin C and gulonic acid from Vitamin C mother liquor |
| 02/15/2006 | CN1733746A Method for coke benzene oxydation to produce maleic anhydride |
| 02/15/2006 | CN1733690A Processes for preparing 2-(omega-alkoxycarbonylalkanoyl)-4- butanolides omega-hydroxy-(omega-3)-keto fatty esters, and derivatives thereof |
| 02/15/2006 | CN1241919C Method for purifying compound of anhydrides aromatic carboxylic acid |
| 02/15/2006 | CN1241918C Prepn process of high purity alkenyl succinic anhydride |
| 02/15/2006 | CN1241909C Carboxylic acid derivatives as IP antagonists |
| 02/15/2006 | CN1241887C Process for simultaneous production of maleic anhydride and its hydrogenated derivatives |
| 02/14/2006 | US6998494 Preparation of trans-fused 3,3a,8,12b-tetrahydro-2h-dibenzo[3,4:6,7]cyclohepta[1,2-b]furan derivatives |
| 02/14/2006 | US6998423 Sulfonyl-amino or carbonyl-amino derivatives; osteoporosis bone disorders; therapeutic drug or kits including anti-resorptive agents, anabolic agents; |
| 02/14/2006 | US6998407 For prophylaxis and therapy of chronic or acute inflammatory or autoimmune diseases, those associated with aberrant lymphocyte or monocyte accumulation such as arthritis, asthma, atherosclerosis, diabetic nephropathy, inflammatory bowel disease |
| 02/14/2006 | US6998214 For producing high memory capacity storage media |
| 02/14/2006 | US6997961 N-heteroarylmethyl-m-phenylenediamine derivatives-containing dyes for keratin fibers and novel n-heteroarylmethyl-m-phenylenediamine derivatives |
| 02/14/2006 | CA2245197C Unsaturated derivatives in position -4 of 6-tert-butyl-1, 1-dimethylindan and their use in human or veterinary medicine and in cosmetics |
| 02/14/2006 | CA2241094C Tri-substituted phenyl derivatives useful as pde iv inhibitors |
| 02/14/2006 | CA2241093C Tri-substituted phenyl derivatives useful as pde iv inhibitors |
| 02/09/2006 | WO2006015065A2 Liquid phase synthesis of methylene lactones using oxynitride catalyst |
| 02/09/2006 | WO2006015023A2 Liquid phase synthesis of methylene lactones using novel catalyst |
| 02/09/2006 | WO2006014134A1 Novel piperidine derivative for the treatment of depression |
| 02/09/2006 | WO2006013929A1 Composition for accelerating calcium absorption |
| 02/09/2006 | WO2005118511A3 Compounds, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
| 02/09/2006 | WO2005113529A3 Novel cylopenta[b]benzofuran derivatives and the utilization thereof |
| 02/09/2006 | WO2005112913B1 Transthyretin stabilization |
| 02/09/2006 | WO2003090691A3 Method and compositions for identifying anti-hiv therapeutic compounds |
| 02/09/2006 | US20060030737 Lithiating a 1-hydroxy-1-arylalkane, carbonylating with dialkylformamide, and reactng with Grignard reagent; diols may be further reacted with phosphorus compounds to form fused ring dioxaphosphepines; their transition metal complexes and their oxides; fused ring phospholanes; and diphosphinites |
| 02/09/2006 | US20060030719 Cis-3,5-disubstituted-dihydro-furan-2-ones and the preparation and use thereof |
| 02/09/2006 | US20060030713 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation |
| 02/09/2006 | US20060030618 Vanilloid receptor ligands and their use in treatments |
| 02/09/2006 | US20060030616 Anhydride modified cantharidin analogues useful in the treatment of cancer |
| 02/09/2006 | US20060030599 Sulphonamide derivatives |
| 02/09/2006 | US20060030561 2-Benzyl-2-hydroxy-4-methyl-4-phenylpentanoic acid (1-oxo-1,3-dihydroisobenzofuran-5-yl)amide for example; treating type II diabetes, obesity, hypertension, arteriosclerosis, or glaucoma |
| 02/09/2006 | US20060030553 Cell adhesion inhibitors |
| 02/09/2006 | US20060030543 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease |
| 02/09/2006 | DE102004035164A1 Neue o-Aminophenol-Derivate und diese Verbindungen enthaltende Färbemittel New o-aminophenol derivatives and compounds containing colorants |
| 02/09/2006 | CA2576073A1 Novel piperidine derivative for the treatment of depression |
| 02/09/2006 | CA2576022A1 Composition for accelerating calcium absorption |
| 02/08/2006 | EP1623973A1 Platinum complex |
| 02/08/2006 | EP1623704A1 Therapeutic agent |
| 02/08/2006 | EP1622890A2 Blockers of the quorum sensing system of gram-negative bacteria |
| 02/08/2006 | EP1622889A2 Pesticidal (dihalopropenyl)phenylalkyl substituted benzodioxolane and benzodioxole derivatives |
| 02/08/2006 | EP1622886A2 Substituted amino carboxylic acids as inhibitors of protein tyrosine phosphatase-1b |
| 02/08/2006 | EP1622866A1 Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators |
| 02/08/2006 | EP1622865A2 Novel bioisosteres of actinonin |
| 02/08/2006 | EP1318978B1 N-acylsulfonamide apoptosis promoters |
| 02/08/2006 | EP1309328A4 Cox-2 inhibitors and the prevention of the side effects of radiation therapy |
| 02/08/2006 | EP0932600B1 Sulfonamide substituted aspartic acid interleukin-1beta converting enzyme inhibitors |
| 02/08/2006 | CN1732163A Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 02/08/2006 | CN1732162A 1,2,4-triaminobenzenderivater nyttige for behandling AV forstyrrelser i sentralnervesystemet |
| 02/08/2006 | CN1732161A 1,3-diamino-2-hydroxypropane pro-drug derivatives |
| 02/08/2006 | CN1732156A Biphenyl derivatives and their use as fungicides |
| 02/08/2006 | CN1732149A Process for the synthesis of 3.3a.6.6a-tetrahydro-2h-cyclopentan[b]furan-2-one |
| 02/08/2006 | CN1732147A Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 02/08/2006 | CN1732146A Cycloalkyl inhibitors of potassium channel function |
| 02/08/2006 | CN1731993A Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases |
| 02/08/2006 | CN1240696C Process of producing monocholo benzen anhydride by continuous liquid phase oxydation |
| 02/08/2006 | CN1240695C Technical method for extracting salvianolic acid B from radix salivae miltiorrhizae |